 The emergence of drug resistant tuberculosis as well as the requirement for long expensive and toxic drug regimens impede efforts to control and eliminate TB . Therefore theres a need for effective and affordable anti mycobacterial agents which can shorten the duration of therapy and are active against

@highlight Synthesis of a series of
@highlight  alkyl and aryl nitrofurantoin analogues.
@highlight Evaluation of antimycobacterial H37Rv activity and cytotoxicity.
@highlight  Octyl analogue
@highlight MIC
@highlight  0.5M was 30 fold more potency than nitrofurantoin.
@highlight Analogue
@highlight  100 Fold more selective towards
@highlight  stood as anti TB validated hit.
